tradingkey.logo
搜尋

Apimeds Pharmaceuticals US Inc

APUS
添加自選
5.150USD
+0.230+4.67%
收盤 07-31 16:00美東報價延遲15分鐘
64.77M總市值
虧損本益比TTM

Apimeds Pharmaceuticals US Inc

5.150
+0.230+4.67%

關於 Apimeds Pharmaceuticals US Inc 公司

Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.

Apimeds Pharmaceuticals US Inc簡介

公司代碼APUS
公司名稱Apimeds Pharmaceuticals US Inc
上市日期May 09, 2025
CEOMenon (Vin)
員工數量2
證券類型Ordinary Share
年結日May 09
公司地址100 Matawan Road
城市MATAWAN
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編07747
電話18482015010
網址https://www.apimedsus.com/
公司代碼APUS
上市日期May 09, 2025
CEOMenon (Vin)

Apimeds Pharmaceuticals US Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Vin Menon
Vin Menon
Chief Executive Officer, Director - Designee
Chief Executive Officer, Director - Designee
--
--
Mr. Amir Dossal
Mr. Amir Dossal
Director - Designee
Director - Designee
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--

常見問題

Apimeds Pharmaceuticals US Inc的前五大股東是誰?

Apimeds Pharmaceuticals US Inc的前五大股東如下:Mr. Erik C. Emerson
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有